599
Views
7
CrossRef citations to date
0
Altmetric
Review Articles

The effects of bisphenols on the cardiovascular system

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 66-87 | Received 08 Nov 2021, Accepted 20 Feb 2022, Published online: 08 Apr 2022

References

  • Aboul Ezz HS, Khadrawy YA, Mourad IM. 2015. The effect of bisphenol A on some oxidative stress parameters and acetylcholinesterase activity in the heart of male albino rats. Cytotechnology. 67(1):145–155.
  • Aekplakorn W, Chailurkit LO, Ongphiphadhanakul B. 2015. Association of serum bisphenol a with hypertension in thai population. Int J Hypertens. 2015:594189.1):69–76.
  • Bosquiazzo VL, Varayoud J, Munoz-de-Toro M, Luque EH, Ramos JG. 2010. Effects of neonatal exposure to bisphenol A on steroid regulation of vascular endothelial growth factor expression and endothelial cell proliferation in the adult rat uterus. Biol Reprod. 82(1):86–95.
  • Bousoumah R, Leso V, Iavicoli I, Huuskonen P, Viegas S, Porras SP, Santonen T, Frery N, Robert A, Ndaw S. 2021. Biomonitoring of occupational exposure to bisphenol A, bisphenol S and bisphenol F: a systematic review. Sci Total Environ. 783:146905.
  • Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. 1995. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect. 103(6):608–612.
  • Buteau-Lozano H, Velasco G, Cristofari M, Balaguer P, Perrot-Applanat M. 2008. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism. J Endocrinol. 196(2):399–412.
  • Cai S, Rao X, Ye J, Ling Y, Mi S, Chen H, Fan C, Li Y. 2020. Relationship between urinary bisphenol a levels and cardiovascular diseases in the U.S. adult population, 2003–2014. Ecotoxicol Environ Saf. 192:110300.
  • Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. 2008. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003–2004. Environ Health Perspect. 116(1):39–44.
  • Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. 2005. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect. 113(4):391–395.
  • Calafat AM, Weuve J, Ye X, Jia LT, Hu H, Ringer S, Huttner K, Hauser R. 2009. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect. 117(4):639–644.
  • Camacho L, Lewis SM, Vanlandingham MM, Olson GR, Davis KJ, Patton RE, Twaddle NC, Doerge DR, Churchwell MI, Bryant MS, et al. 2019. A two-year toxicology study of bisphenol A (BPA) in Sprague-Dawley rats: CLARITY-BPA core study results. Food Chem Toxicol. 132:110728.
  • Catenza CJ, Farooq A, Shubear NS, Donkor KK. 2021. A targeted review on fate, occurrence, risk and health implications of bisphenol analogues. Chemosphere. 268:129273.
  • Colorado-Yohar SM, Castillo-González AC, Sánchez-Meca J, Rubio-Aparicio M, Sánchez-Rodríguez D, Salamanca-Fernández E, Ardanaz E, Amiano P, Fernández MF, Mendiola J, et al. 2021. Concentrations of bisphenol-A in adults from the general population: A systematic review and meta-analysis. Sci Total Environ. 775:145755.
  • Commission Directive 2011/8/EU of 28 January 2011. 2011. Amending Directive 2002/72/EC as regards the restriction of use of Bisphenol A in plastic infant feeding bottles. Official Journal of the European Union. L 26/11. [accessed 2021 Feb 01]. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32011L0008&from=EN
  • Commission Regulation (EU) 2016/1179 of 19 July 2016. 2016. Amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures. Official Journal of the European Union. L 195/11. [accessed 2022 Jan 02]. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R1179&from=EN
  • Commission Regulation (EU) 2016/2235 of 12 December 2016. 2016. Amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards bisphenol A. Official Journal of the European Union. L 337/3. [accessed 2022 Jan 28]. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R2235&from=EN
  • Commission Regulation (EU) No 10/2011 of 14 January 2011. 2011. On plastic materials and articles intended to come into contact with food. Official Journal of the European Union. L 12/1. [accessed 2022 Jan 13]. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32011R0010&from=EN
  • Corbel T, Gayrard V, Puel S, Lacroix MZ, Berrebi A, Gil S, Viguié C, Toutain PL, Picard-Hagen N. 2014. Bidirectional placental transfer of Bisphenol A and its main metabolite, Bisphenol A-Glucuronide, in the isolated perfused human placenta. Reprod Toxicol. 47:51–58.
  • Csanády GA, Oberste-Frielinghaus HR, Semder B, Baur C, Schneider KT, Filser JG. 2002. Distribution and unspecific protein binding of the xenoestrogens bisphenol A and daidzein. Arch Toxicol. 76(5–6):299–305.
  • Danzi S, Klein I. 2003. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep. 5(6):513–520.
  • Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Schouten EG. 2000. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC study. Atheroscler risk communities. Circulation. 102(11):1239–1244.
  • den Braver-Sewradj SP, van Spronsen R, Hessel EVS. 2020. Substitution of bisphenol A: a review of the carcinogenicity, reproductive toxicity, and endocrine disruption potential of alternative substances. Crit Rev Toxicol. 50(2):128–147.
  • Deutschmann A, Hans M, Meyer R, Haberlein H, Swandulla D. 2013. Bisphenol A inhibits voltage-activated Ca(2+) channels in vitro: mechanisms and structural requirements. Mol Pharmacol. 83(2):501–511.
  • Dodds EC, Lawson W. 1936. Synthetic strogenic Agents without the Phenanthrene Nucleus. Nature. 137(3476):996–996.
  • Doerge DR, Twaddle NC, Vanlandingham M, Fisher JW. 2010a. Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats. Toxicol Appl Pharmacol. 247(2):158–165.
  • Doerge DR, Twaddle NC, Woodling KA, Fisher JW. 2010b. Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys. Toxicol Appl Pharmacol. 248(1):1–11.
  • Duty SM, Mendonca K, Hauser R, Calafat AM, Ye X, Meeker JD, Ackerman R, Cullinane J, Faller J, Ringer S. 2013. Potential sources of bisphenol A in the neonatal intensive care unit. Pediatrics. 131(3):483–489.
  • ECHA. 2017. MSC unanimously agrees that Bisphenol A is an endocrine disruptor (ECHA/PR/17/12). Helsinki: European Chemicals Agency [accessed 2022 January 18]. https://echa.europa.eu/-/msc-unanimously-agrees-that-bisphenol-a-is-an-endocrine-disruptor.
  • ECHA. 2018. BPA being replaced by BPS in thermal paper, ECHA survey finds (ECHA/NR/18/31). Helsinki: European Chemicals Agency; [accessed 2022 January 10]. https://echa.europa.eu/-/bpa-being-replaced-by-bps-in-thermal-paper-echa-survey-finds.
  • EFSA. 2021. Bisphenol A: EFSA draft opinion proposes lowering the tolerable daily intake. European Food Safety Authority [accessed 2022 January 19]. https://www.efsa.europa.eu/en/news/bisphenol-efsa-draft-opinion-proposes-lowering-tolerable-daily-intake.
  • Eilebrecht E, Wenzel A, Windshügel B, Keminer O. 2019. Bewertung des endokrinen potenzials von bisphenol alternativstoffen in umweltrelevanten verwendungen. Dessau-Roßlau: German Environment Agency. Texte 123/2019.
  • Fang C, Ning B, Waqar AB, Niimi M, Li S, Satoh K, Shiomi M, Ye T, Dong S, Fan J. 2014. Bisphenol A exposure enhances atherosclerosis in WHHL rabbits. PLoS One. 9(10):e110977.
  • Fang C, Ning B, Waqar AB, Niimi M, Li S, Satoh K, Shiomi M, Ye T, Dong S, Fan J. 2015. Bisphenol A exposure induces metabolic disorders and enhances atherosclerosis in hyperlipidemic rabbits. J Appl Toxicol. 35(9):1058–1070.
  • Feiteiro J, Mariana M, Gloria S, Cairrao E. 2018. Inhibition of L-type calcium channels by Bisphenol A in rat aorta smooth muscle. J Toxicol Sci. 43(10):579–586.
  • Ferguson M, Lorenzen-Schmidt I, Pyle WG. 2019. Bisphenol S rapidly depresses heart function through estrogen receptor-β and decreases phospholamban phosphorylation in a sex-dependent manner . Sci Rep. 9(1):15948.
  • Fernandez MO, Bourguignon NS, Arocena P, Rosa M, Libertun C, Lux-Lantos V. 2018. Neonatal exposure to bisphenol A alters the hypothalamic-pituitary-thyroid axis in female rats. Toxicol Lett. 285:81–86.
  • Foster WG, Kubwabo C, Kosarac I, Gregorovich S, Aryal G, Coleman K. 2019. Free bisphenol A (BPA), BPA-glucuronide (BPA-G), and total BPA concentrations in maternal serum and urine during pregnancy and umbilical cord blood at delivery. Emerg Contaminant. 5:279–287.
  • Fredette NC, Meyer MR, Prossnitz ER. 2018. Role of GPER in estrogen-dependent nitric oxide formation and vasodilation. J Steroid Biochem Mol Biol. 176:65–72.
  • Freitas J, Cano P, Craig-Veit C, Goodson ML, Furlow JD, Murk AJ. 2011. Detection of thyroid hormone receptor disruptors by a novel stable in vitro reporter gene assay. Toxicol in Vitro. 25(1):257–266.
  • Gayrard V, Lacroix MZ, Grandin, FC, Collet SH, Mila H, Viguié C, Gély CA, Rabozzi B, Bouchard M, Léandri R, et al. 2019. Oral Systemic Bioavailability of Bisphenol A and Bisphenol S in Pigs. Environ Health Perspect. 127(7):77005.
  • Gayrard V, Lacroix MZ, Collet SH, Viguié C, Bousquet-Melou A, Toutain PL, Picard-Hagen N. 2013. High Bioavailability of Bisphenol A from Sublingual Exposure. Environ Health Perspect. 121(8):951–956.
  • Gerona RR, Pan J, Zota AR, Schwartz JM, Friesen M, Taylor JA, Hunt PA, Woodruff TJ. 2016. Direct measurement of Bisphenol A (BPA), BPA glucuronide and BPA sulfate in a diverse and low-income population of pregnant women reveals high exposure, with potential implications for previous exposure estimates: a cross-sectional study. Environ Health. 15(1):50.
  • Ghisari M, Bonefeld-Jorgensen EC. 2005. Impact of environmental chemicals on the thyroid hormone function in pituitary rat GH3 cells. Mol Cell Endocrinol. 244(1–2):31–41.
  • Ginsberg G, Rice DC. 2009. Does rapid metabolism ensure negligible risk from bisphenol A? Environ Health Perspect. 117(11):1639–1643.
  • Gould JC, Leonard LS, Maness SC, Wagner BL, Conner K, Zacharewski T, Safe S, McDonnell DP, Gaido KW. 1998. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol Cell Endocrinol. 142(1–2):203–214.
  • Grandin FC, Lacroix MZ, Gayrard V, Viguié C, Mila H, de Place A, Vayssière C, Morin M, Corbett J, Gayrard C, et al. 2019. Is bisphenol S a safer alternative to bisphenol A in terms of potential fetal exposure ? Placental transfer across the perfused human placenta. Chemosphere. 221:471–478.
  • Gray GM, Cohen JT, Cunha G, Hughes C, McConnell EE, Rhomberg L, Sipes IG, Mattison D. 2004. Weight of the evidence evaluation of low-dose reproductive and developmental effects of bisphenol A. Hum Ecol Risk Assess. 10(5):875–921.
  • Heindel JJ, Belcher S, Flaws JA, Prins GS, Ho S-M, Mao J, Patisaul HB, Ricke W, Rosenfeld CS, Soto AM, et al. 2020. Data integration, analysis, and interpretation of eight academic CLARITY-BPA studies. Reprod Toxicol. 98:29–60.
  • Hercog K, Maisanaba S, Filipič M, Sollner-Dolenc M, Kač L, Žegura B. 2019. Genotoxic activity of bisphenol A and its analogues bisphenol S, bisphenol F and bisphenol AF and their mixtures in human hepatocellular carcinoma (HepG2) cells. Sci Total Environ. 687:267–276.
  • Hiroi H, Tsutsumi O, Takeuchi T, Momoeda M, Ikezuki Y, Okamura A, Yokota H, Taketani Y. 2004. Differences in serum bisphenol a concentrations in premenopausal normal women and women with endometrial hyperplasia. Endocr J. 51(6):595–600.
  • Hodges YK, Tung L, Yan X-D, Graham JD, Horwitz KB, Horwitz LD. 2000. Estrogen Receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation. 101(15):1792–1798.
  • Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. 2002. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod. 17(11):2839–2841.
  • Inoue K, Kato K, Yoshimura Y, Makino T, Nakazawa H. 2000. Determination of bisphenol A in human serum by high-performance liquid chromatography with multi-electrode electrochemical detection. J Chromatogr B Biomed Sci Appl. 749(1):17–23.
  • Ishikawa T, Chijiwa T, Hagiwara M, Mamiya S, Hidaka H. 1989. Thyroid hormones directly interact with vascular smooth muscle strips. Mol Pharmacol. 35(6):760–765.
  • Jarrar Y, Lee S-J. 2021. The functionality of UDP-glucuronosyltransferase genetic variants and their association with drug responses and human diseases. J Pers Med. 11(6):554.
  • Jazbutyte V, Arias-Loza PA, Hu K, Widder J, Govindaraj V, von Poser-Klein C, Bauersachs J, Fritzemeier KH, Hegele-Hartung C, Neyses L, et al. 2007. Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Cardiovasc Res. 77(4):774–781.
  • Jiang S, Liu H, Zhou S, Zhang X, Peng C, Zhou H, Tong Y, Lu Q. 2020. Association of bisphenol A and its alternatives bisphenol S and F exposure with hypertension and blood pressure: a cross-sectional study in China. Environ Pollut. 257:113639.
  • Joint Research Centre, Institute for Health and Consumer Protection. 2010. Updated European Union risk assessment report 4,4′-isopropylidenediphenol (bisphenol-A): human health addendum of February 2008. https://doi.org/10.2788/40301.
  • Karalius VP, Harbison JE, Plange-Rhule J, van Breemen RB, Li G, Huang K, Durazo-Arvizu RA, Mora N, Dugas LR, Vail L, et al. 2014. Bisphenol A (BPA) Found in Humans and Water in Three Geographic Regions with Distinctly Different Levels of Economic Development. Environ Health Insights. 8:1–3.
  • Kataria A, Levine D, Wertenteil S, Vento S, Xue J, Rajendiran K, Kannan K, Thurman JM, Morrison D, Brody R, et al. 2017. Exposure to bisphenols and phthalates and association with oxidant stress, insulin resistance, and endothelial dysfunction in children. Pediatr Res. 81(6):857–864.
  • Kazemi S, Bahramifar N, Moghadamnia AA, Jorsarae SGA. 2016. Detection of bisphenol A and nonylphenol in rat’s blood serum, tissue and impact on reproductive system. Electron Physician. 8(8):2772–2780.
  • Kenda M, Fonović U, Kos J, Dolenc M. 2022. The effect of endocrine disrupting chemicals on the vitronectin-receptor (integrin αvβ3)-mediated cell adhesion of human umbilical vein endothelial cells. Toxicol in Vitro. 79:105275.
  • Khmiri I, Côté J, Mantha M, Khemiri R, Lacroix M, Gely C, Toutain PL, Picard-Hagen N, Gayrard V, Bouchard M. 2020. Toxicokinetics of bisphenol-S and its glucuronide in plasma and urine following oral and dermal exposure in volunteers for the interpretation of biomonitoring data. Environ Int. 138:105644.
  • Kim I, Je HD, Gallant C, Zhan Q, Riper DV, Badwey JA, Singer HA, Morgan KG. 2000. Ca2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta. J Physiol. 526 Pt 2(2):367–374.
  • Kim MJ, Moon MK, Kang GH, Lee KJ, Choi SH, Lim S, Oh BC, Park DJ, Park KS, Jang HC, et al. 2014. Chronic exposure to bisphenol A can accelerate atherosclerosis in high-fat-fed apolipoprotein E knockout mice. Cardiovasc Toxicol. 14(2):120–128.
  • Kim YH, Kim CS, Park S, Han SY, Pyo MY, Yang M. 2003. Gender differences in the levels of bisphenol A metabolites in urine. Biochem Biophys Res Commun. 312(2):441–448.
  • Kitamura S, Jinno N, Ohta S, Kuroki H, Fujimoto N. 2002. Thyroid hormonal activity of the flame retardants tetrabromobisphenol A and tetrachlorobisphenol A. Biochem Biophys Res Commun. 293(1):554–559.
  • Kitamura S, Suzuki T, Sanoh S, Kohta R, Jinno N, Sugihara K, Yoshihara S, Fujimoto N, Watanabe H, Ohta S. 2005. Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds. Toxicol Sci. 84(2):249–259.
  • Koch HM, Kolossa-Gehring M, Schröter-Kermani C, Angerer J, Brüning T. 2012. Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation. J Expo Sci Environ Epidemiol. 22(6):610–616.
  • Kodaira T, Kato I, Li JUN, Mochizuki T, Hoshino M, Usaki Y, Oguri H, Yanaihara N. 2000. Novel ELISA for the Measurement of Immunoreactive Bisphenol A. Biomed Res. 21(2):117–121.
  • Kolatorova Sosvorova L, Chlupacova T, Vitku J, Vlk M, Heracek J, Starka L, Saman D, Simkova M, Hampl R. 2017. Determination of selected bisphenols, parabens and estrogens in human plasma using LC-MS/MS. Talanta. 174:21–28.
  • Kolšek K, Gobec M, Mlinarič Raščan I, Sollner Dolenc M. 2015. Screening of bisphenol A, triclosan and paraben analogues as modulators of the glucocorticoid and androgen receptor activities. Toxicol in Vitro. 29(1):8–15.
  • Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139(10):4252–4263.
  • Kurebayashi H, Betsui H, Ohno Y. 2003. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide. Toxicol Sci. 73(1):17–25.
  • Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, Melzer D. 2008. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA. 300(11):1303–1310.
  • Le Fol V, Aït-Aïssa S, Cabaton N, Dolo L, Grimaldi M, Balaguer P, Perdu E, Debrauwer L, Brion F, Zalko D. 2015. Cell-specific biotransformation of benzophenone-2 and bisphenol-s in zebrafish and human in vitro models used for toxicity and estrogenicity screening. Environ Sci Technol. 49(6):3860–3868.
  • Lee J, Kim S, Choi K, Ji K. 2018. Effects of bisphenol analogs on thyroid endocrine system and possible interaction with 17β-estradiol using GH3 cells . Toxicol in Vitro. 53:107–113.
  • Lee S, Kim C, Youn H, Choi K. 2017. Thyroid hormone disrupting potentials of bisphenol A and its analogues - in vitro comparison study employing rat pituitary (GH3) and thyroid follicular (FRTL-5) cells. Toxicol in Vitro. 40:297–304.
  • Lee YJ, Ryu HY, Kim HK, Min CS, Lee JH, Kim E, Nam BH, Park JH, Jung JY, Jang DD, et al. 2008. Maternal and fetal exposure to bisphenol A in Korea. Reprod Toxicol. 25(4):413–419.
  • Lehmler HJ, Liu B, Gadogbe M, Bao W. 2018. Exposure to bisphenol A, bisphenol F, and bisphenol S in US adults and children: the national health and nutrition examination survey 2013–2014. ACS Omega. 3(6):6523–6532.
  • Li A, Zhuang T, Shi W, Liang Y, Liao C, Song M, Jiang G. 2020. Serum concentration of bisphenol analogues in pregnant women in China. Sci Total Environ. 707:136100.
  • Liao C, Kannan K. 2012. Determination of free and conjugated forms of bisphenol A in human urine and serum by liquid chromatography-tandem mass spectrometry. Environ Sci Technol. 46(9):5003–5009.
  • Liao C, Liu F, Alomirah H, Loi VD, Mohd MA, Moon HB, Nakata H, Kannan K. 2012. Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ Sci Technol. 46(12):6860–6866.
  • Lin CY, Shen FY, Lian GW, Chien KL, Sung FC, Chen PC, Su TC. 2015. Association between levels of serum bisphenol A, a potentially harmful chemical in plastic containers, and carotid artery intima-media thickness in adolescents and young adults. Atherosclerosis. 241(2):657–663.
  • Lind PM, Lind L. 2011. Circulating levels of bisphenol A and phthalates are related to carotid atherosclerosis in the elderly. Atherosclerosis. 218(1):207–213.
  • Liu J, Martin JW. 2019. Comparison of bisphenol A and bisphenol S Percutaneous absorption and biotransformation. Environ Health Perspect. 127(6):67008.
  • Liu X, Sakai H, Nishigori M, Suyama K, Nawaji T, Ikeda S, Nishigouchi M, Okada H, Matsushima A, Nose T, et al. 2019. Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors. Toxicol Appl Pharmacol. 377:114610.
  • Liu Z, Wolff MS, Moline J. 2005. Analysis of environmental biomarkers in urine using an electrochemical detector. J Chromatogr B Analyt Technol Biomed Life Sci. 819(1):155–159.
  • LOI no 2012–1442 du 24 Décembre 2012. Visant à la suspension de la fabrication, de l’importation, de l’exportation et de la mise sur le marché de tout conditionnement à vocation alimentaire contenant du bisphénol A. 2012. Journal officiel de la république française. [accessed 2022 Jan 16]. https://www.legifrance.gouv.fr/download/pdf?id=Pghms4HnY4dy_JnI0G3Kua3U0jSD7UEbpl3dAMzpeEM=
  • Long X, Burke KA, Bigsby RM, Nephew KP. 2001. Effects of the xenoestrogen bisphenol A on expression of vascular endothelial growth factor (VEGF) in the rat. Exp Biol Med (Maywood)). 226(5):477–483.
  • Mazur CS, Kenneke JF, Hess-Wilson JK, Lipscomb JC. 2010. Differences between human and rat intestinal and hepatic bisphenol A glucuronidation and the influence of alamethicin on in vitro kinetic measurements. Drug Metab Dispos. 38(12):2232–2238.
  • Mehboob H, Tahir IM, Iqbal T, Akhter N, Munir N, Riaz M. 2017. Genetic polymorphisms. 1st ed. Vol. 159. Rijeka: InTech.
  • Melzer D, Gates P, Osborne NJ, Henley WE, Cipelli R, Young A, Money C, McCormack P, Schofield P, Mosedale D, et al. 2012. Urinary bisphenol a concentration and angiography-defined coronary artery stenosis. PLoS One. 7(8):e43378.
  • Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. 2010. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06. PLoS One. 5(1):e8673.
  • Milligan SR, Balasubramanian AV, Kalita JC. 1998. Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay. Environ Health Perspect. 106(1):23–26.
  • Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, Hataya Y, Shimatsu A, Kuzuya H, Nakao K. 2002. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab. 87(11):5185–5190.
  • Oh J, Choi JW, Ahn YA, Kim S. 2018. Pharmacokinetics of bisphenol S in humans after single oral administration. Environ Int. 112:127–133.
  • O’Reilly AO, Eberhardt E, Weidner C, Alzheimer C, Wallace BA, Lampert A. 2012. Bisphenol A binds to the local anesthetic receptor site to block the human cardiac sodium channel. PLoS One. 7(7):e41667.
  • Ojamaa K, Balkman C, Klein IL. 1993. Acute effects of triiodothyronine on arterial smooth muscle cells. Ann Thorac Surg. 56(1):S61–S66.
  • Ojamaa K, Klemperer JD, Klein I. 1996. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid. 6(5):505–512.
  • Pal S, Sarkar K, Nath PP, Mondal M, Khatun A, Paul G. 2017. Bisphenol S impairs blood functions and induces cardiovascular risks in rats. Toxicol Rep. 4:560–565.
  • Pande P, Fleck SC, Twaddle NC, Churchwell MI, Doerge DR, Teeguarden JG. 2019. Comparative estrogenicity of endogenous, environmental and dietary estrogens in pregnant women II: total estrogenicity calculations accounting for competitive protein and receptor binding and potency. Food Chem Toxicol. 125:341–353.
  • Pant J, Ranjan P, Deshpande SB. 2011. Bisphenol A decreases atrial contractility involving NO-dependent G-cyclase signaling pathway. J Appl Toxicol. 31(7):698–702.
  • Park KW, Dai HB, Ojamaa K, Lowenstein E, Klein I, Sellke FW. 1997. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg. 85(4):734–738.
  • Pavlovičová M, Karmažínová M, Huláková S, Lacinová L. 2014. Bisphenol A differently inhibits CaV3.1, Ca V3.2 and Ca V3.3 calcium channels. Naunyn Schmiedebergs Arch Pharmacol. 387(2):153–163.
  • Philips EM, Jaddoe VWV, Asimakopoulos AG, Kannan K, Steegers EAP, Santos S, Trasande L. 2018. Bisphenol and phthalate concentrations and its determinants among pregnant women in a population-based cohort in the Netherlands, 2004-5. Environ Res. 161:562–572.
  • Philips EM, Trasande L, Kahn LG, Gaillard R, Steegers EAP, Jaddoe VWV. 2019. Early pregnancy bisphenol and phthalate metabolite levels, maternal hemodynamics and gestational hypertensive disorders. Hum Reprod. 34(2):365–373.
  • PlasticsEurope. 2022. Bisphenol A Europe. [accessed 2022 January 17]. https://bisphenol-a-europe.org/regulatory-framework/european-legislation-on-chemicals/.
  • Posnack NG, Brooks D, Chandra A, Jaimes R, Sarvazyan N, Kay M. 2015. Physiological response of cardiac tissue to bisphenol A: alterations in ventricular pressure and contractility. Am J Physiol Heart Circ Physiol. 309(2):H267–275.
  • Pottenger LH, Domoradzki JY, Markham DA, Hansen SC, Cagen SZ, Waechter JM Jr. 2000. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci. 54(1):3–18.
  • Prudencio TM, Swift LM, Guerrelli D, Cooper B, Reilly M, Ciccarelli N, Sheng J, Jaimes R, Posnack NG. 2021. Bisphenol S and bisphenol F are less disruptive to cardiac electrophysiology, as compared with bisphenol A. Toxicol Sci. 183(1):214–226.
  • Rameshrad M, Imenshahidi M, Razavi BM, Iranshahi M, Hosseinzadeh H. 2018. Bisphenol A vascular toxicity: protective effect of Vitis vinifera (grape) seed extract and resveratrol. Phytother Res. 32(12):2396–2407.
  • Ranciere F, Botton J, Slama R, Lacroix MZ, Debrauwer L, Charles MA, Roussel R, Balkau B, Magliano DJ, Group D, et al. 2019. Exposure to bisphenol A and bisphenol S and incident type 2 diabetes: a case-cohort study in the French cohort D. Environ Health Perspect. 127(10):107013.
  • Rosenmai AK, Dybdahl M, Pedersen M, Alice van Vugt-Lussenburg BM, Wedebye EB, Taxvig C, Vinggaard AM. 2014. Are structural analogues to bisphenol a safe alternatives? Toxicol Sci. 139(1):35–47.
  • Rotimi OA, Olawole TD, De Campos OC, Adelani IB, Rotimi SO. 2021. Bisphenol A in Africa: A review of environmental and biological levels. Sci Total Environ. 764:142854.
  • Rottgen TS, Fancher IS, Asano S, Widlanski TS, Dick GM. 2014. Bisphenol A activates BK channels through effects on α and β1 subunits. Channels (Austin). 8(3):249–257.
  • Sajiki J, Takahashi K, Yonekubo J. 1999. Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 736(1–2):255–261.
  • Salter DR, Dyke CM, Wechsler AS. 1992. Triiodothyronine (T3) and cardiovascular therapeutics: a review. J Card Surg. 7(4):363–374.
  • Sartain CV, Hunt PA. 2016. An old culprit but a new story: bisphenol A and “NextGen” bisphenols. Fertil Steril. 106(4):820–826.
  • Sasso AF, Pirow R, Andra SS, Church R, Nachman RM, Linke S, Kapraun DF, Schurman SH, Arora M, Thayer KA, et al. 2020. Pharmacokinetics of bisphenol A in humans following dermal administration. Environ Int. 144:106031.
  • Saura M, Marquez S, Reventun P, Olea-Herrero N, Arenas MI, Moreno-Gomez-Toledano R, Gomez-Parrizas M, Munoz-Moreno C, Gonzalez-Santander M, Zaragoza C, et al. 2014. Oral administration of bisphenol A induces high blood pressure through angiotensin II/CaMKII-dependent uncoupling of eNOS. FASEB J. 28(11):4719–4728.
  • Savastano S, Tarantino G, D'Esposito V, Passaretti F, Cabaro S, Liotti A, Liguoro D, Perruolo G, Ariemma F, Finelli C, et al. 2015. Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population. J Trans Med. 13(1):169.
  • Schönfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. 2002. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect. 110(11):A703–A707.
  • Shankar A, Teppala S, Sabanayagam C. 2012. Bisphenol A and peripheral arterial disease: results from the NHANES. Environ Health Perspect. 120(9):1297–1300.
  • Shapiro GD, Dodds L, Arbuckle TE, Ashley-Martin J, Fraser W, Fisher M, Taback S, Keely E, Bouchard MF, Monnier P, et al. 2015. Exposure to phthalates, bisphenol A and metals in pregnancy and the association with impaired glucose tolerance and gestational diabetes mellitus: the MIREC study. Environ Int. 83:63–71.
  • Song S, Duan Y, Zhang T, Zhang B, Zhao Z, Bai X, Xie L, He Y, Ouyang JP, Huang X, et al. 2019. Serum concentrations of bisphenol A and its alternatives in elderly population living around e-waste recycling facilities in China: associations with fasting blood glucose. Ecotoxicol Environ Saf. 169:822–828.
  • Soriano S, Alonso-Magdalena P, García-Arévalo M, Novials A, Muhammed SJ, Salehi A, Gustafsson J-A, Quesada I, Nadal A. 2012. Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of langerhans: role of estrogen receptor β. PLoS One. 7(2):e31109.
  • Sparks R, Ulrich CM, Bigler J, Tworoger SS, Yasui Y, Rajan KB, Porter P, Stanczyk FZ, Ballard-Barbash R, Yuan X, et al. 2004. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res. 6(5):R488–498.
  • Staples CA, Dorn PB, Klecka GM, O’Block ST, Harris LR. 1998. A review of the environmental fate, effects, and exposures of bisphenol A. Chemosphere. 36(10):2149–2173.
  • Stowell CL, Barvian KK, Young Peter CM, Bigsby RM, Verdugo Dawn E, Bertozzi CR, Widlanski TS. 2006. A role for sulfation-desulfation in the uptake of bisphenol A into breast tumor cells. Chem Biol. 13(8):891–897.
  • Sugiura-Ogasawara M, Ozaki Y, Sonta SI, Makino T, Suzumori K. 2005. Exposure to bisphenol A is associated with recurrent miscarriage. Hum Reprod. 20(8):2325–2329.
  • Sui Y, Park SH, Helsley RN, Sunkara M, Gonzalez FJ, Morris AJ, Zhou C. 2014. Bisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice. J Am Heart Assoc. 3(2):e000492.
  • Sun H, Shen OX, Wang XR, Zhou L, Zhen SQ, Chen XD. 2009. Anti-thyroid hormone activity of bisphenol A, tetrabromobisphenol A and tetrachlorobisphenol A in an improved reporter gene assay. Toxicol in Vitro. 23(5):950–954.
  • Tait S, Tassinari R, Maranghi F, Mantovani A. 2015. Bisphenol A affects placental layers morphology and angiogenesis during early pregnancy phase in mice. J Appl Toxicol. 35(11):1278–1291.
  • Takeuchi T, Tsutsumi O. 2002. Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels. Biochem Biophys Res Commun. 291(1):76–78.
  • Taylor JA, Vom Saal FS, Welshons WV, Drury B, Rottinghaus G, Hunt PA, Toutain PL, Laffont CM, VandeVoort CA. 2011. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ Health Perspect. 119(4):422–430.
  • Teeguarden J, Hanson-Drury S, Fisher JW, Doerge DR. 2013. Are typical human serum BPA concentrations measurable and sufficient to be estrogenic in the general population? Food Chem Toxicol. 62:949–963.
  • Teeguarden JG, Twaddle NC, Churchwell MI, Doerge DR. 2016. Urine and serum biomonitoring of exposure to environmental estrogens I: bisphenol A in pregnant women. Food Chem Toxicol. 92:129–142.
  • Thayer KA, Doerge DR, Hunt D, Schurman SH, Twaddle NC, Churchwell MI, Garantziotis S, Kissling GE, Easterling MR, Bucher JR, et al. 2015. Pharmacokinetics of bisphenol A in humans following a single oral administration. Environ Int. 83:107–115.
  • Thomsen C, Lundanes E, Becher G. 2002. Brominated flame retardants in archived serum samples from Norway: a study on temporal trends and the role of age. Environ Sci Technol. 36(7):1414–1418.
  • Tominaga T, Negishi T, Hirooka H, Miyachi A, Inoue A, Hayasaka I, Yoshikawa Y. 2006. Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC-MS/MS method. Toxicology. 226(2–3):208–217.
  • Vale C, Neves JS, von Hafe M, Borges-Canha M, Leite-Moreira A. 2019. The role of thyroid hormones in heart failure. Cardiovasc Drugs Ther. 33(2):179–188.
  • Valokola MG, Karimi G, Razavi BM, Kianfar M, Jafarian AH, Jaafari MR, Imenshahidi M. 2019. The protective activity of nanomicelle curcumin in bisphenol A-induced cardiotoxicity following subacute exposure in rats. Environ Toxicol. 34(3):319–329.
  • Vandenberg LN, Chahoud I, Padmanabhan V, Paumgartten FJR, Schoenfelder G. 2010. Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ Health Perspect. 118(8):1051–1054.
  • Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. 2007. Human exposure to bisphenol A (BPA). Reprod Toxicol. 24(2):139–177.
  • Völkel W, Colnot T, Csanády GA, Filser JG, Dekant W. 2002. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol. 15(10):1281–1287.
  • Vom Saal FS, Welshons WV. 2014. Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine, and that BPA causes numerous hazards from multiple routes of exposure. Mol Cell Endocrinol. 398(1–2):101–113.
  • Wan Y, Xia W, Yang S, Pan X, He Z, Kannan K. 2018. Spatial distribution of bisphenol S in surface water and human serum from Yangtze River watershed, China: implications for exposure through drinking water. Chemosphere. 199:595–602.
  • Wang F, Hua J, Chen M, Xia Y, Zhang Q, Zhao R, Zhou W, Zhang Z, Wang B. 2012. High urinary bisphenol A concentrations in workers and possible laboratory abnormalities. Occup Environ Med. 69(9):679–684.
  • Widder J, Pelzer T, von Poser-Klein C, Hu K, Jazbutyte V, Fritzemeier KH, Hegele-Hartung C, Neyses L, Bauersachs J. 2003. Improvement of endothelial dysfunction by selective estrogen receptor-alpha stimulation in ovariectomized SHR. Hypertension. 42(5):991–996.
  • Willhite CC, Ball GL, McLellan CJ. 2008. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration. J Toxicol Environ Health B Crit Rev. 11(2):69–146.
  • Wolff MS, Teitelbaum SL, Windham G, Pinney SM, Britton JA, Chelimo C, Godbold J, Biro F, Kushi LH, Pfeiffer CM, et al. 2007. Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect. 115(1):116–121.
  • Xue B, Pamidimukkala J, Lubahn DB, Hay M. 2007. Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol. 292(4):H1770–1776.
  • Yamada H, Furuta I, Kato EH, Kataoka S, Usuki Y, Kobashi G, Sata F, Kishi R, Fujimoto S. 2002. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod Toxicol. 16(6):735–739.
  • Yasuda S, Wu P-S, Hattori E, Tachibana H, Yamada K. 2004. Simultaneous determination of isoflavones and bisphenol A in rat serum by high-performance liquid chromatography coupled with coulometric array detection. Biosci Biotechnol Biochem. 68(1):51–58.
  • Zhu Q, Jia J, Wang Y, Zhang K, Zhang H, Liao C, Jiang G. 2019. Spatial distribution of parabens, triclocarban, triclosan, bisphenols, and tetrabromobisphenol A and its alternatives in municipal sewage sludges in China. Sci Total Environ. 679:61–69.
  • Zhuang W, Wu K, Wang Y, Zhu H, Deng Z, Peng L, Zhu G. 2015. Association of serum bisphenol-A concentration and male reproductive function among exposed workers. Arch Environ Contam Toxicol. 68(1):38–45.
  • Zoeller RT, Bansal R, Parris C. 2005. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology. 146(2):607–612.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.